| Targeting the ubiquitin-proteasome pathway to overcome anti-cancer drug resistance S Narayanan, CY Cai, YG Assaraf, HQ Guo, Q Cui, L Wei, JJ Huang, ... Drug Resistance Updates 48, 100663, 2020 | 235 | 2020 |
| Immuno-oncology agent IPI-549 is a modulator of P-glycoprotein (P-gp, MDR1, ABCB1)-mediated multidrug resistance (MDR) in cancer: In vitro and in vivo AA De Vera, P Gupta, Z Lei, D Liao, S Narayanan, Q Teng, SE Reznik, ... Cancer letters 442, 91-103, 2019 | 54 | 2019 |
| Cytotoxicity assessment of lipid-based self-emulsifying drug delivery system with Caco-2 cell model: Cremophor EL as the surfactant P Bu, S Narayanan, D Dalrymple, X Cheng, ATM Serajuddin European Journal of Pharmaceutical Sciences 91, 162-171, 2016 | 54 | 2016 |
| Assessment of cell viability and permeation enhancement in presence of lipid-based self-emulsifying drug delivery systems using Caco-2 cell model: Polysorbate 80 as the surfactant P Bu, Y Ji, S Narayanan, D Dalrymple, X Cheng, ATM Serajuddin European Journal of Pharmaceutical Sciences 99, 350-360, 2017 | 39 | 2017 |
| GSK1904529A, a Potent IGF‐IR Inhibitor, Reverses MRP1‐Mediated Multidrug Resistance P Gupta, M Xie, S Narayanan, YJ Wang, XQ Wang, T Yuan, Z Wang, ... Journal of cellular biochemistry 118 (10), 3260-3267, 2017 | 27 | 2017 |
| CDK inhibitors as sensitizing agents for cancer chemotherapy P Gupta, S Narayanan, DH Yang Protein kinase inhibitors as sensitizing agents for chemotherapy, 125-149, 2019 | 25 | 2019 |
| EGFR and HER2 inhibitors as sensitizing agents for cancer chemotherapy AM Barbuti, GN Zhang, P Gupta, S Narayanan, ZS Chen Protein kinase inhibitors as sensitizing agents for chemotherapy, 1-11, 2019 | 18 | 2019 |
| The novel benzamide derivative, VKNG-2, restores the efficacy of chemotherapeutic drugs in colon cancer cell lines by inhibiting the ABCG2 transporter S Narayanan, NA Gujarati, JQ Wang, ZX Wu, J Koya, Q Cui, VL Korlipara, ... International Journal of Molecular Sciences 22 (5), 2463, 2021 | 15 | 2021 |
| Cabozantinib reverses topotecan resistance in human non-small cell lung cancer NCI-H460/TPT10 cell line and tumor xenograft model ZN Lei, QX Teng, P Gupta, W Zhang, S Narayanan, DH Yang, ... Frontiers in Cell and Developmental Biology 9, 640957, 2021 | 12 | 2021 |
| Overexpression of ABCG2 confers resistance to MLN7243, a ubiquitin-activating enzyme (UAE) inhibitor ZX Wu, Y Yang, JQ Wang, S Narayanan, ZN Lei, QX Teng, L Zeng, ... Frontiers in Cell and Developmental Biology 9, 697927, 2021 | 11 | 2021 |
| Synthesis and characterization of biocompatible bimetallic-semi-aromatic polyester hybrid nanocomposite R Kumar, PK Gupta, S Pandit, NK Jha, J Ruokolainen, KK Kesari, PP Patil, ... Colloids and Surfaces A: Physicochemical and Engineering Aspects 633, 127845, 2022 | 10 | 2022 |
| Synthesis and cytotoxicity studies of stilbene long-chain fatty acid conjugates T Wong, S Narayanan, DP Brown, ZS Chen Journal of Natural Products 83 (5), 1563-1570, 2020 | 10 | 2020 |
| Poly (ADP-ribose) polymerase (PARP) inhibitors as chemosensitizing compounds for the treatment of drug resistant cancers N Silpa, T Qiu-Xu, K Jagadish, W Jingquan, GA Yehuda, RAJ Charles, ... Journal of Molecular and Clinical Medicine 2 (3), 55-67, 2019 | 9 | 2019 |
| VKNG-1 antagonizes ABCG2-mediated multidrug resistance via p-AKT and bcl-2 pathway in colon cancer: in vitro and in vivo study S Narayanan, YF Fan, NA Gujarati, QX Teng, JQ Wang, CY Cai, Y Yang, ... Cancers 13 (18), 4675, 2021 | 8 | 2021 |
| Immuno-oncology agent IPI-549 is a modulator of P-glycoprotein (P-gp, MDR1, ABCB1)-mediated multidrug resistance (MDR) in cancer AA De Vera, P Gupta, Z Lei, D Liao, S Narayanan, Q Teng vitro, 2019 | 8 | 2019 |
| The spleen tyrosine kinase inhibitor, entospletinib (GS-9973) restores chemosensitivity in lung cancer cells by modulating ABCG2-mediated multidrug resistance S Narayanan, ZX Wu, JQ Wang, H Ma, N Acharekar, J Koya, ... International Journal of Biological Sciences 17 (10), 2652, 2021 | 5 | 2021 |
| Anticancer effect of Indanone-based thiazolyl hydrazone derivative on p53 mutant colorectal cancer cell lines: An in vitro and in vivo study S Narayanan, QX Teng, ZX Wu, U Nazim, N Karadkhelkar, N Acharekar, ... Frontiers in Oncology 12, 949868, 2022 | 4 | 2022 |
| Comparative study of effect of aluminium chloride and aluminium hydroxide on serum biochemical parameters in wistar albino rats S Narayanan Int J Pharm Bio Sci 5 (1), 253-258, 2014 | 4 | 2014 |
| ABCB1 limits the cytotoxic activity of TAK-243, an inhibitor of the ubiquitin-activating enzyme UBA1 Z Wu, Y Yang, Z Lei, S Narayanan, J Wang, Q Teng, M Murakami, ... Frontiers in bioscience (Landmark edition) 27 (1), 5, 2022 | 3 | 2022 |
| Synthesis, Characterization and Cytotoxic Effect of Some New Thiazolyl Hydrazone Derivatives of 1-Indanone. U Nazim, S Narayanan, M Ali, KM Khan, B Ali, J Li, ZS Chen, M Ahmed, ... Journal of the Chemical Society of Pakistan 43 (2), 2021 | 2 | 2021 |
